Anti-Corruption Provisions. (a) The Consultant certifies that it has received a copy of and agrees to comply with Act No. 2-2018, known as the Anti-Corruption Code for the New Puerto Rico (“Act No. 2-2018”), and with the Puerto Rico Government Ethics Law of 2011, Act No. 1-2012, as amended (“Act No. 1-2012”).
(b) The Consultant shall furnish a sworn statement to the effect that neither the Consultant nor any president, vice president, executive director or any member of a board of officials or board of directors, or any person performing equivalent functions for the Consultant has been convicted of or has pled guilty to any of the crimes listed in Article 6.8 of Act No. 8- 2017, as amended, known as the Act for the Administration and Transformation of Human Resources in the Government of Puerto Rico (“Act No. 8-2017”), or any of the crimes included in Act No. 2-2018.
(c) The Consultant hereby certifies that it has not been convicted in Puerto Rico or United States Federal Court under Articles 4.2, 4.3 or 5.7 of Act No. 1-2012, for any of the crimes listed in Articles 250 through 266 of Act No. 146-2012, as amended, known as the Puerto Rico Penal Code (“Act No. 146-2012”), any of the crimes typified in Act No. 2-2018, or any other felony that involves misuse of public funds or property, including, but not limited to, the crimes mentioned in Article 6.8 of Act No. 8-2017.
(d) The Authority shall have the right to terminate this Agreement in the event the Consultant is convicted in Puerto Rico or United States Federal Court under Articles 4.2, 4.3 or
Anti-Corruption Provisions. Each Party represents and warrants to the other Party that such Party has not, directly or indirectly, offered, promised, paid, authorized or given, and each Party agrees that such Party will not, in the future, offer, promise, pay, authorize or give, money or anything of value, directly or indirectly, to any Government Official (as defined below) or Other Covered Party (as defined below) for the purpose, pertaining to this Agreement, of: (i) influencing any act or decision of such Government Official or Other Covered Party; (ii) inducing such Government Official or Other Covered Party to do or omit to do an act in violation of a lawful duty; (iii) securing any improper advantage; or (iv) inducing such Government Official or Other Covered Party to influence the act or decision of a Governmental Authority, in order to obtain or retain business, or direct business to, any person or entity, in any way related to this Agreement.
Anti-Corruption Provisions. 12.1 The Seller represents, warrants and undertakes to Pfizer that:
(i) it has the full power, right and authority to enter and perform the Contract and that it will comply with all relevant laws, regulations, codes of practice, operating procedures and guidelines and will obtain and maintain all covenants, licences, approvals and permissions necessary to fulfil its obligations under the Contract; and
(ii) it will not (directly or indirectly) offer, pay or authorise the offer/ payment of any money or the giving of anything of value or do any other thing in order to exert improper influence on any Government Official; and
(iii) it has not (directly or indirectly) in the five (5) years immediately preceding the Contract offered, paid or authorised the offer/payment of any money or the giving of anything of value or the doing of anything in order to exert improper influence on any Government Official; and
(iv) all information provided by it in the Third Party Entity Anti-Corruption Due Diligence Questionnaire, is complete and accurate.
12.2 The Seller will be deemed to have repeated the above representations, warranties and undertakings if, during the term of the Contract, it comes under the control of a Government Official or it becomes aware that any individual with significant responsibility for performing the Seller’s obligations hereunder (or a close relative of such an individual), has become a Government Official.
12.3 During the term of the Contract and for a period of three (3) years after the final payment from Pfizer has been made under it, the Seller shall promptly arrange for Pfizer and its auditors to have such access to records relating to the arrangements covered by this Contract as they may reasonably require in order to verify the propriety of any payments (including disbursements, expenses or charges) proposed or made to or by the Seller.
Anti-Corruption Provisions. 13.1. The Seller represents and warrants that:
a. The Seller is licensed, registered or qualified under local law, regulations, policies and administrative requirements to provide the goods or services in this agreement, and no regulations or other obligations prohibit it from providing such goods or services;
b. The Seller has not and will not in the future directly or indirectly offer a pay, or authorize the offer or payment, of any money or anything of value in an effort to influence any Government Official or any other person in order for Pfizer to improperly obtain or retain business or to gain an improper business advantage, and, has not accepted, and will not accept in the future, such a payment;
c. The Seller has been provided with a copy of Pfizer’s International Anti-Bribery Principles and has communicated such Principles to all persons acting on its behalf in connection with work for Pfizer, including agents or subcontractors;
d. Any information provided by The Seller to Pfizer in connection with Pfizer’s Anti-Corruption Due Diligence is complete, truthful and accurate and The Seller agrees to inform Pfizer if any responses in the due diligence questionnaire with respect to The Seller or any individuals identified in the due diligence questionnaire or their Family Relatives, as defined therein, change during the performance of this agreement;
e. The Seller will (i) provide truthful and complete documentation supporting, in reasonable detail, the work performed and any expenses incurred, (ii) maintain true, accurate, and complete invoices, reports, statements, books, and other records, and (iii) secure pre-authorization in writing from Pfizer for any extraordinary expenditure; and
f. The Seller will permit, during the term of the agreement and for three years after final payment has been made under the agreement, Pfizer’s internal and external auditor’s access to any relevant books, documents, paper and records involving transactions related to the agreement. Where the agreement involves clinical studies, the contract shall include acceptable safeguards to ensure confidentiality.
g. The Seller will complete and submit to Pfizer, the Third Party Annual Compliance Certification at an annual interval, upon request by Pfizer.
h. The Seller agrees that upon request of Pfizer, any persons acting on behalf of himself in connection with work for Pfizer, will complete anti-corruption training provided by Pfizer, and will notify Pfizer of any persons that ...
Anti-Corruption Provisions. The Seller represents, warrants and undertakes to Pfizer that: (i) it has the full power, right and authority to enter and perform the Contract and that it will comply with all relevant laws, regulations, codes of practice, operating procedures and guidelines and will obtain and maintain all covenants, licences, approvals and permissions necessary to fulfil its obligations under the Contract; and (ii) it will not (directly or indirectly) offer, pay or authorise the offer/ payment of any money or the giving of anything of value or do any other thing in order to exert improper influence on any Government Official; and (iii) it has not (directly or indirectly) in the five (5) years immediately preceding the Contract offered, paid or authorised the offer/payment of any money or the giving of anything of value or the doing of anything in order to exert improper influence on any Government Official; and (iv) all information provided by it in the Third Party Entity Anti-Corruption Due Diligence Questionnaire, is complete and accurate.
Anti-Corruption Provisions a) The Consultant certifies that it has received a copy of and agrees to comply with Act No. 2-2018, known as the Anti-Conuption Code for the New Pue1io Rico ("Act No. 2-2018"), and with the Puerto Rico Government Ethics Law of 2011, Act No. 1-2012, as amended ("Act No. 1-2012").
b) The Consultant shall furnish a sworn statement to the effect that neither the Consultant nor any president, vice president, executive director or any member of a board of officials or board of directors, or any person performing equivalent functions for the Consultant has been convicted of or has pled guilty to any of the crimes listed in Aliicle 6.8 of Act No. 8- 2017, as amended, known as the Act for the Administration and Transfmmation of Human Resources in the Government of Pue1io Rico ("Act No. 8-2017"), or any of the crimes included in Act No. 2-2018.
c) The Consultant hereby ce1iifies that it has not been convicted in Pue1io Rico or United States Federal Comi under A1iicles 4.2, 4.3 or 5.7 of Act No. 1-2012, for any of the crimes listed in Articles 250 through 266 of Act No. 146-2012, as amended, known as the Pue1io Rico Penal Code ("Act No. 146-2012"), any of the crimes typified in Act No. 2-2018, or any other felony that involves misuse of public funds or property, including, but not limited to, the crimes mentioned in Aliicle 6.8 of Act No. 8-2017.
d) The Authority shall have the right to te1minate this Agreement in the event the Consultant is convicted in Pue1io Rico or United States Federal Court under Articles 4.2, 4.3 or
Anti-Corruption Provisions. 1. In their performance of obligations arising out of this Agreement, the Parties shall act in compliance with all applicable legal regulations, including, without limitation, anti-corruption rules valid in the Czech Republic, including Act No. 40/2009 Coll., Criminal Code (“Criminal Code”), Civil Code, Act No. 262/2006 Coll., Labor Code and Act No. 40/1995 Coll., on Regulation of Advertising, as amended, as well as with any applicable ethical and other industry codes of conduct, including but not limited to those laws enacted pursuant to international conventions such as the 1997 OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and the 2003 United Nations Convention Against Corruption.
2. The marketing co-operation under this Agreement is provided solely for the purpose as specified in Article 1 of this Agreement. The provision of the marketing co-operation is not connected with the establishment of any other rights or obligations of the Parties, in particular, with any obligation to purchase, order or recommend the products and/or services of the Partner. The Event Organizer explicitly represents and warrants that the Contribution provided by the Partner hereunder will not be used for providing unearned benefits to persons authorized to recommend, purchase, order or otherwise procure for Partner's products and/or services in conflict with applicable provisions of the Act on Regulation of Advertising, provisions for protection against unfair competition and/or the Criminal Code.
3. Each Party undertakes not to tolerate or engage in, and shall ensure that its directors, officers, employees and other representatives abstain from, any form of corruption or bribery, including the offering, promising or giving or the soliciting, demanding or extorting of any undue payment or other advantage to obtain or retain business or other improper advantage.
Anti-Corruption Provisions. 13.1 Seller represents, warrants, and covenants to Buyer that: (i) it has the full power, right and authority to enter and perform the Contract and that it will comply with all relevant laws, regulations, codes of practice, operating procedures and guidelines and will obtain and maintain all covenants, licences, approvals and permissions necessary to fulfill its obligations under the Contract; (ii) it does and will comply with all applicable laws, statutes, regulations and codes relating to anti-bribery and anti-corruption, including, but not limited to, the U.S. Foreign Corrupt Practices Act of 1977 (the “FCPA”) and the U.K. Bribery Act 2010 (the “Bribery Act”) and does not and will not engage in any activity, practice or conduct which would constitute an offense under Sections 1, 2 or 6 of the Bribery Act if such activity, practice or conduct had been carried out in the United Kingdom, or under the FCPA, or which would result in Seller’s violation of any provision thereof; and (iii) it will not (directly or indirectly) offer, pay, give or authorize the offer, payment, or giving of any money or anything of value to a Government Official or political party or candidate for the purpose of corrupting the individual’s duties and attempting to influence that individual to provide business or retain business of Buyer or Seller, or do any other thing in order to exert improper influence on such individual.
Anti-Corruption Provisions. Chiva has not, directly or indirectly, offered, promised, paid, authorized or given, and will not in the future, offer, promise, pay, authorize or give, money or anything of value, directly or indirectly, to any Government Official (as defined below) or Other Covered Party (as defined below) for the purpose, pertaining to this Agreement, of: (i) influencing any act or decision of the Government Official or Other Covered Party; (ii) inducing the Government Official or Other Covered Party to do or omit to do an act in violation of a lawful duty; (iii) securing any improper advantage; or (iv) inducing the Government Official or Other Covered Party to influence the act or decision of a government or government instrumentality, in order to obtain or retain business, or direct business to, any person or entity, in any way related to this Agreement.
Anti-Corruption Provisions. Akebia and Licensee have not, directly or indirectly, offered, promised, paid, authorized or given, and will not in the future, offer, promise, pay, authorize or give, money or anything of value, directly or indirectly, to any Government Official (as defined below) or Other Covered Party (as defined below) for the purpose, pertaining to this Agreement, of: (i) influencing any act or decision of the Government Official or Other Covered Party; (ii) inducing the Government Official or Other Covered Party to do or omit to do an act in violation of a lawful duty; (iii) securing any improper advantage; or (iv) inducing the Government Official or Other Covered Party to influence the act or decision of a government or government instrumentality, in order to obtain or retain business, or direct business to, any person or entity, in any way related to this Agreement.
